Novadaq Technologies Inc.  

(Public, TSE:NDQ)   Watch this stock  
Find more results for NDQ
19.00
-0.79 (-3.99%)
Apr 15 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 18.33 - 19.50
52 week 10.42 - 27.39
Open 19.50
Vol / Avg. 6,102.00/3,455.00
Mkt cap 1.05B
P/E     -
Div/yield     -
EPS -0.52
Shares 55.05M
Beta 0.25
Inst. own     -
Apr 28, 2014
Q1 2014 NOVADAQ TECHNOLOGIES INC Earnings Release (Estimated) Add to calendar
Apr 8, 2014
Novadaq Technologies Inc at Needham Healthcare Conference
Mar 20, 2014
NOVADAQ TECHNOLOGIES INC at Lazard MedTech, Diagnostics & Healthcare IT Snowbird Conference
Mar 13, 2014
NOVADAQ TECHNOLOGIES INC at Barclays Healthcare Conference
Feb 26, 2014
NOVADAQ TECHNOLOGIES INC at RBC Capital Markets Healthcare Conference
Feb 6, 2014
Q4 2013 NOVADAQ TECHNOLOGIES INC Earnings Release
Feb 6, 2014
Q4 2013 NOVADAQ TECHNOLOGIES INC Earnings Conference Call
  

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -25.26% -63.68%
Operating margin -30.39% -20.67%
EBITD margin - -10.02%
Return on average assets -6.68% -16.52%
Return on average equity -8.62% -21.68%
Employees 56 -
CDP Score - -

Address

Suite 202, 5090 Explorer Drive
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

Description

Novadaq Technologies Inc. develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. It manufactures SPY systems, FIREFLY hardware components, and PINPOINT Systems at its manufacturing facility located in Richmond British Columbia. The Company�s SPY imaging core technology platform provides clinically anatomic and physiologic images during a variety of complex surgical procedures. The SPY technology platform allows for the development of specific devices based on the needs of the surgeon and the specific application. Effective February 1, 2011, it acquired Laser System Business for Transmyocardial Revascularization.

Officers and directors

Arun Menawat Ph.D. President, Chief Executive Officer, Director
Stephen Purcell Chief Financial Officer
Mary Kay Baggs Senior Vice President - Marketing and Business Development
Roger Deck Vice President - Operations
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Age: 82
G. Steven Burrill Independent Director
Aaron Davidson Independent Director
Age: 44
Harold O. Koch Jr. Independent Director
William A. MacKinnon Independent Director
Age: 66